Advocacy

The National Fibromyalgia & Chronic Pain Association, which serves as the voice for an estimated 10 million people in the United States who suffer from fibromyalgia, is committed to working with the healthcare professional (HCP) community and third-party payers to provide the best possible treatment options for people affected by fibromyalgia. This section offers updates on the many challenges currently facing HCPs and their patients, such as the denial of medication and other treatment options, as well as efforts designed to improve access and delivery of care to patients.

Read more...

NFMCPA Comments to Noridian Healthcare Solutions

nfmcpa

 

 

 

 

Read more...

NIAMS Meeting about FM & Chronic Pain

On March 27, 2014, Jan Chambers, President of the National Fibromyalgia & Chronic Pain Association along with Rae Marie Gleason, Medical Education & Research Director for the Association, met in Bethesda, Maryland, at the National Institute of Arthritis and Musculoskeletal and Skin Diseases office with

Read more...

For Noridian Healthcare Solutions, National Pain Group is a PISSER

In a March 10, 2014 letter, Jan Favero Chambers, President & Founder of the National Fibromyalgia & Chronic Pain Association, lambasted Noridian Healthcare Solutions' DRAFT POLICY DL 34692 (LCD for Drugs of Abuse Testing) for proposing that definitive testing for urine drug screens is not covered. While this blog is a bit out of the ordinary, it demonstrates the ignorance of third party payers and their lack of commitment to patient constituents and the public health at large.

Read more...

FDA FM Public Patient-Focused Meeting

“What is your thinking about the risk/benefit profile? How much risk are you willing to tolerate? No drug is completely safe.  You all recognize that, but there is a scale there, and we need to hear from you how much risk you’re willing to tolerate,” said Director Dr. Bob Rappaport.

Read more...